Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06293807Phase 1Completed
Phase 1, randomised trial in Periodontal disease (PD) comparing Xylocaine, Marcaine and Placebo (3 arms). Primary endpoints: Change in pain using Visual Analog Scale at 48 hours, Number of Ibuprofen administered at 48 hours and 1 more. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06293807.